The case of Dr. Ankur Patel, a gastroenterologist who has garnered both adulation and condemnation for his unorthodox liver treatments, has thrust medical ethics into the global spotlight. Dr. Patel, based in Ahmedabad, became an internet sensation after posting videos of his high-risk procedures, which have saved lives but also led to severe complications. His methods, which include experimental drug cocktails and off-label interventions, have attracted patients from across Asia who could not afford conventional care. Yet Indian medical regulators have accused him of violating ethical guidelines and jeopardising patient safety.
In contrast, the British medical community’s response to a similar dilemma a decade ago set a benchmark. When Dr. James Thornton, a London hepatologist, faced pressure to trial a novel therapy during a hepatitis C outbreak, he refused, citing patient safety and professional ethics. The case led to a review by the General Medical Council, which reinforced the principle of evidence-based care. The UK’s approach, prioritising institutional integrity over individual innovation, has been cited by the World Medical Association as a model for balancing compassion with caution.
The Patel controversy highlights a deeper geopolitical tension. As India asserts its soft power in medical tourism, its regulatory frameworks remain fragmented. Dr. Patel’s supporters argue that his work exposes a failing public health system, while critics say it undermines trust in Indian medicine. The British model offers a template, but its export requires local adaptation. For now, the global medical community watches as one doctor’s boldness tests the limits of ethical practice.
